Shoulder Innovations, Inc. (NYSE:SI – Get Free Report) CFO Jeffrey Points acquired 2,000 shares of Shoulder Innovations stock in a transaction dated Friday, March 13th. The shares were bought at an average price of $15.00 per share, with a total value of $30,000.00. Following the transaction, the chief financial officer directly owned 70,785 shares in the company, valued at approximately $1,061,775. The trade was a 2.91% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Shoulder Innovations Trading Down 1.0%
NYSE SI opened at $15.07 on Friday. The firm’s fifty day moving average price is $13.77 and its 200 day moving average price is $13.87. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $17.94. The company has a debt-to-equity ratio of 0.11, a current ratio of 11.07 and a quick ratio of 9.55. The company has a market capitalization of $311.11 million and a price-to-earnings ratio of -0.07.
Shoulder Innovations (NYSE:SI – Get Free Report) last issued its quarterly earnings data on Tuesday, March 10th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.42) by $0.04. Shoulder Innovations had a negative return on equity of 37.68% and a negative net margin of 85.29%.The company had revenue of $14.42 million for the quarter, compared to analyst estimates of $12.69 million. On average, sell-side analysts expect that Shoulder Innovations, Inc. will post -0.56 earnings per share for the current fiscal year.
Institutional Trading of Shoulder Innovations
Analysts Set New Price Targets
A number of equities research analysts have weighed in on SI shares. The Goldman Sachs Group reiterated a “buy” rating on shares of Shoulder Innovations in a research note on Friday, January 9th. Weiss Ratings reissued a “sell (e)” rating on shares of Shoulder Innovations in a research report on Monday, December 29th. BTIG Research increased their target price on shares of Shoulder Innovations from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, March 11th. Finally, Morgan Stanley upped their price objective on Shoulder Innovations from $18.00 to $23.00 and gave the company an “overweight” rating in a research note on Tuesday, December 2nd. Five analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $20.80.
Check Out Our Latest Analysis on Shoulder Innovations
About Shoulder Innovations
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Read More
Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.
